Filing Flows › Lifevantage (LFVN) › Q3 2026 › vs Q2 2026
Lifevantage (LFVN) Q3 2026 vs Q2 2026 (quarter over quarter)
Lifevantage's revenue fell $5.3M (-12%) from $42.4M in Q2 2026 to $37.1M in Q3 2026.
Lifevantage, Q3 2026: revenue $37.1M (-22% year over year), operating margin -0.4%, net loss $196K, operating cash flow $533K. The chart draws each line against Q2 2026, the increases inside each band.
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $37.1M | $42.4M | −$5.3M | -12% |
| Net loss | $196K | −$1.3M | $1.5M | — |
| Costs & expenses | $37.3M | $42.4M | −$5.1M | -12% |
| Operating costs | $37.3M | $40.7M | −$3.5M | -8% |
| Income tax | $12K | $417K | −$405K | -97% |
| Cost of revenue | $9.1M | $9.3M | −$186K | -2% |
| Research & development | $200K | $200K | $0 | 0% |
| SG&A | $12.7M | $13.9M | −$1.1M | -8% |
| Other operating costs | $15.2M | $17.3M | −$2.1M | -12% |
| Operating cash sources | $1.0M | $960K | $76K | +8% |
| Depreciation & amortization | $730K | $697K | $33K | +5% |
| Share-based compensation | $306K | $263K | $43K | +16% |
| Net loss absorbed | $196K | −$1.3M | $1.5M | — |
| Working capital & other | $307K | −$2.5M | $2.8M | — |
| Operating cash flow | $533K | $4.8M | −$4.2M | -89% |
| Capital expenditures | $1.2M | $1.0M | $203K | +20% |
| Negative free cash flow (OCF − capex) | $707K | −$3.7M | $4.4M | — |
Questions
How much did Lifevantage's revenue grow quarter over quarter in Q3 2026?
Lifevantage's revenue fell $5.3M (-12%) from $42.4M in Q2 2026 to $37.1M in Q3 2026.